{"id":"W4296628505","doi":"10.1016/j.jacig.2022.07.009","title":"Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities","year":2022,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology Global","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; University of Toronto","funders":"National Health and Medical Research Council; Nutricia North America; National Institute of Allergy and Infectious Diseases; Medical Research Council; Financial Markets Foundation for Children; National Institutes of Health; Regeneron Pharmaceuticals; AstraZeneca; Aimmune Therapeutics; CSL Behring; Danone; Sanofi; Genentech; Food Allergy Research and Education; Pfizer","keywords":"Medicine; Placebo; Tolerability; Atopic dermatitis; Peanut allergy; Concomitant; Allergy; Adverse effect; Randomized controlled trial; Food allergy; Anaphylaxis; Asthma; Internal medicine; Subgroup analysis; Dermatology; Immunology; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000417787,0.0001068347,0.0005196107,0.00007862596,0.00009392346,0.000005220743,0.000133158,0.00009823159,0.0001798828],"category_scores_gemma":[0.0001038977,0.00007933651,0.00009019516,0.0001451486,0.0005115272,0.00004636463,0.0001199652,0.0006620946,4.723776e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005169158,"about_ca_system_score_gemma":0.000140107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003087611,"about_ca_topic_score_gemma":0.00003455788,"domain_scores_codex":[0.9984382,0.0002727288,0.0007098234,0.000136391,0.0002587361,0.000184135],"domain_scores_gemma":[0.9991382,0.0002421277,0.0002876554,0.0001316548,0.000127194,0.0000731179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07818755,0.004536629,0.7965048,0.00003279845,0.005939702,0.0007464638,0.0003253284,0.00005801595,0.00005984277,0.003091625,0.0003027446,0.1102145],"study_design_scores_gemma":[0.01402067,0.01384605,0.9619338,0.00006137753,0.00001213008,0.0003900698,0.0003032358,0.000005320221,0.000004390337,0.0002187096,0.00913202,0.00007226191],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939142,0.004486503,0.000004322912,0.0008579566,0.0001580174,0.0001028634,0.000008391075,0.000003427186,0.0004643551],"genre_scores_gemma":[0.9942949,0.005290044,0.0001013584,0.0001903566,0.00003536911,0.000001020166,0.000005652567,0.000005894659,0.00007534197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.165429,"threshold_uncertainty_score":0.3235249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01569641041579029,"score_gpt":0.3115846625116886,"score_spread":0.2958882520958984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}